En Es
Categories

BioFire Diagnostics.

BioFire Diagnostics, a subsidiary of bioMérieux SA, offers easy-to-use clinical molecular diagnostic solutions based on a symptom-driven diagnostic method that combines a broad grouping of probable pathogenic causes into a single, rapid test. Its specialties include infectious disease diagnostics, multiplex PCR, real-tim ...
Gold member
Products Covid-19Summary
Close

Covid-19 BioFire Diagnostics.

Clinical Laboratory

Respiratory Panel with SARS-CoV-2
BioFire® Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2

The BioFire® Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2 is intended for the detection of SARS-CoV-2 and also detects 21 additional respiratory pathogens to help clinicians quickly rule in and rule out other common causes of respiratory illness in about 45 minutes. The BioFire RP2.1 is now authorized under an EUA for use on both the BioFire 2.0 and BioFire Torch Systems.
More details
Close

About BioFire Diagnostics.

BioFire Diagnostics, a subsidiary of bioMérieux SA, offers easy-to-use clinical molecular diagnostic solutions based on a symptom-driven diagnostic method that combines a broad grouping of probable pathogenic causes into a single, rapid test. Its specialties include infectious disease diagnostics, multiplex PCR, real-time PCR instruments and reagents, hi-res melting instruments and kits, molecular diagnostics, and syndromic testing.
FaceBook Twitter Google+ Linked in
Respiratory Panel with SARS-CoV-2

Respiratory Panel with SARS-CoV-2

Model: BioFire® Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2
Request Information

Description:

The BioFire® Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2 is intended for the detection of SARS-CoV-2 and also detects 21 additional respiratory pathogens to help clinicians quickly rule in and rule out other common causes of respiratory illness in about 45 minutes.
Read More

Full Description

Description

The BioFire® Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2 is intended for the detection of SARS-CoV-2 and also detects 21 additional respiratory pathogens to help clinicians quickly rule in and rule out other common causes of respiratory illness in about 45 minutes. The BioFire RP2.1 is now authorized under an EUA for use on both the BioFire 2.0 and BioFire Torch Systems. Request Information

Send A Message To This Supplier

* Required Information
* Email
To
BioFire Diagnostics. (Respiratory Panel with SARS-CoV-2)
* Message

Copyright © 2000-2020 TradeMed.com. All rights reserved. | Terms And Conditions